Author Topic: Mayzent (siponimod, BAF312) for active SPMS, RRMS  (Read 948 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
Novartis fast tracks siponimod (BAF312) for RRMS
« on: April 26, 2017, 10:03:01 am »
Fast on the heels of the approval of Ocrevus, BAF312 (siponimod) is about to be made available to us. From MedPage Today, April 25--"Novartis Fast Tracks Early MS Drug":

https://www.medpagetoday.com/Neurology/MultipleSclerosis/64789
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
161 Views
Last post April 01, 2019, 04:00:21 pm
by agate
0 Replies
79 Views
Last post May 06, 2019, 09:17:34 pm
by agate
1 Replies
150 Views
Last post October 02, 2019, 06:23:25 am
by agate
0 Replies
103 Views
Last post October 31, 2019, 08:49:09 am
by agate
0 Replies
70 Views
Last post January 29, 2020, 09:35:32 pm
by agate